Drawing for WHERE HEALTHCARE AND SCIENCE CONVERGE

USPTO serial 85175434

WHERE HEALTHCARE AND SCIENCE CONVERGE

Reviewed by CopyMark Law Group

Reg. 4199188Status 710
Filing date
Status date
Registration date
Aug 28, 2012
Examiner
CHARLON, BARNEY
Law office

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with WHERE HEALTHCARE AND SCIENCE CONVERGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher D. Olszyk, Jr.

Christopher D. Olszyk, Jr. FOX ROTHSCHILD LLP997 Lenox Drive, Bldg. 3Lawrenceville, NJ 08648-2311UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035[ Business consulting services for the pharmaceutical and health care industries, namely, pharmaceutical care management programs in the nature of cost management and drug utilization review for pharmaceutical benefit plans for private and public agencies, organizations, institutions, and individuals; Business research services, namely, providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy utilization and costs reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly, namely, drug utilization review research for the pharmaceutical and health care industries ]SECTION 8 - CANCELLEDSep 1, 2010
036[ Providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries, namely, research about patient reimbursement for pharmaceuticals and financing the research of others in the field of pharmacoeconomics; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly by outcomes assessment and drug use and utilization for the pharmaceutical and health care industries, namely, financing the research of others ]SECTION 8 - CANCELLEDSep 1, 2010
041Educational services, namely, providing courses of instruction at the undergraduate, graduate, and post-graduate levels; educational services, namely, providing educational undergraduate, graduate, and post-graduate level research programs for all aspects of pharmaceutical study; providing continuing education conferences, seminars and workshops in the fields of pharmaceutical study, health care, and health sciences; conducting educational conferences and seminars in the fields of the study of pharmacy and the pharmaceutical and health care industries; publication of newsletters, news briefs, and monographs for pharmacists and health care professionals; entertainment services in the nature of presentation of a variety of intercollegiate sporting events, namely, cross-country running, [ cheerleading, rifle, ] basketball, baseball, golf, tennis, softball, and volleyballSECTION 8 - CANCELLEDSep 1, 2010
042[ Technical consulting services in the nature of pharmaceutical technology consulting for pharmaceutical care management programs provided to private and public agencies, organizations, institutions, and individuals for the pharmaceutical and health care industries; Research consulting services in the nature of pharmaceutical research services for pharmaceutical care management programs for private and public agencies, organizations, institutions, and individuals in the pharmaceutical and health care industries; providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy selection, utilization, costs, and reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries, namely, pharmaceutical research services; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly by outcomes assessment and drug use and utilization for the pharmaceutical and health care industries, namely, research in the field of pharmaceuticals ]SECTION 8 - CANCELLEDSep 1, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 10, 2023CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jul 27, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 28, 2021REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 14, 2018NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 14, 2018C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 24, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 16, 2018E815TEAS SECTION 8 & 15 RECEIVED
Aug 28, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 28, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 2012SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 20, 2012REGVLAW OFFICE REGISTRATION REVIEW COMPLETED
Jul 16, 2012CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 25, 2012SUPCSTATEMENT OF USE PROCESSING COMPLETE
Jun 25, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
May 29, 2012IUAFUSE AMENDMENT FILED
May 29, 2012EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 29, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 4, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 1, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 31, 2011ALIEASSIGNED TO LIE
Aug 18, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 17, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2011GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 26, 2011GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 26, 2011CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 23, 2011DOCKASSIGNED TO EXAMINER
Nov 18, 2010MPMKNOTICE OF PSEUDO MARK MAILED
Nov 17, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2010NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance